Pharmatek Solutions Revenue and Competitors
Estimated Revenue & Valuation
- Pharmatek Solutions's estimated annual revenue is currently $3.5M per year.
- Pharmatek Solutions's estimated revenue per employee is $116,000
Employee Data
- Pharmatek Solutions has 30 Employees.
- Pharmatek Solutions grew their employee count by 20% last year.
Pharmatek Solutions's People
Name | Title | Email/Phone |
---|---|---|
1 | Director - Operations and HR | Reveal Email/Phone |
2 | Senior Validation Engineer | Reveal Email/Phone |
Pharmatek Solutions Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $2.9M | 29 | 4% | N/A | N/A |
#2 | $43.4M | 272 | 8% | N/A | N/A |
#3 | $14.1M | 97 | 11% | N/A | N/A |
#4 | $1460M | 8291 | 7% | $1.1B | N/A |
#5 | $310M | 1527 | 20% | N/A | N/A |
#6 | $194.1M | 956 | -5% | N/A | N/A |
#7 | $223.9M | 1080 | -33% | $101.6M | N/A |
#8 | $581.3M | 2708 | 9% | $253.1M | N/A |
#9 | $716.2M | 3528 | 2% | N/A | N/A |
#10 | $801.4M | 3948 | 52% | N/A | N/A |
What Is Pharmatek Solutions?
Pharmatek Solutions offers a full range of technology consulting and GxP compliance services that help emerging life sciences companies deliver more personalized healthcare and better outcomes for patients. Our goal is to help our life sciences customers leverage their existing strengths and develop new capabilities by combining our experience and innovative thinking across in the regulated environment. Our Services: End-to end CSV, Infrastructure Qualification, Equipment Qualification, Onshore/Offshore Managed Services, QA and CSV Audit, Periodic Review, Automation Testing, 21 CFR Part 11 & GAP Assessments, Cloud Validation, End-to-end Clinical Development Have any Questions about Our Services? Talk to us!
keywords:N/AN/A
Total Funding
30
Number of Employees
$3.5M
Revenue (est)
20%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $6.5M | 30 | 11% | N/A |
#2 | $7.8M | 30 | 0% | N/A |
#3 | $3.5M | 30 | 7% | N/A |
#4 | $4.3M | 30 | -9% | N/A |
#5 | $4.3M | 30 | -12% | N/A |